Drug:
Reaction: URINARY TRACT INFECTION
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26932085 |
CA |
50 | |
Thunderclap headache, Harvey-Bradshaw index increased, Mouth ulceration, Conjunctival haemorrhage, Weight decreased, Condition aggravated, Urinary tract infection, Tooth infection, Arthralgia, Abdominal pain, Off label use, Intentional dose omission, Inappropriate schedule of product administration, Incorrect dose administered, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, VORTIOXETINE, LISDEXAMFETAMINE DIMESYLATE, METHYLPHENIDATE HYDROCHLORIDE, ESTRADIOL, PROGESTERONE, |
||||
| 102 | 26932102 |
US |
67 | 2 |
Cardiomegaly, Pathological fracture, Alcohol abuse, Mitral valve incompetence, Hyperkalaemia, Aortic valve incompetence, Lumbosacral plexus lesion, Lyme disease, Type 2 diabetes mellitus, Type IIa hyperlipidaemia, Arteriosclerosis coronary artery, Carotid artery stenosis, Carotid artery occlusion, Fatigue, Enzyme level abnormal, Upper respiratory tract infection, Urinary tract infection, Osteoarthritis, Diabetic vascular disorder, Essential hypertension, Headache, Peripheral vascular disorder, Cerumen impaction, Ill-defined disorder, Angiopathy, Viral infection, Dermatitis contact, Seasonal allergy, Cough, Back pain, Respiratory disorder, Hypernatraemia, Blood osmolarity increased, Aortic valve stenosis, Epicondylitis, Body mass index abnormal, Vitamin D deficiency, Hypercalcaemia, Treatment noncompliance, Rhinitis allergic, |
||||
DENOSUMAB, DENOSUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ENALAPRIL MALEATE, ENALAPRIL, SITAGLIPTIN, ATORVASTATIN CALCIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DESOXIMETASONE, CIPROFLOXACIN HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, |
||||
| 103 | 26932248 |
US |
71 | 2 |
Kidney infection, Blood glucose increased, Fungal infection, Fatigue, Glycosylated haemoglobin increased, Urinary tract infection, Kidney infection, |
||||
ORAL SEMAGLUTIDE, |
||||
| 104 | 26932290 |
US |
79 | 1 |
Urinary tract infection, Cystitis, Muscular weakness, |
||||
FOSCARBIDOPA/FOSLEVODOPA, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, NIFEDIPINE, CARBIDOPA AND LEVODOPA, CLONAZEPAM, TAMSULOSIN HYDROCHLORIDE, |
||||
| 105 | 26932498 |
US |
80 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 106 | 26933079 |
CA |
72 | 2 |
Malignant neoplasm progression, Fall, Contusion, Asthenia, Hospitalisation, Muscular weakness, Hypertension, Blood potassium decreased, Angioplasty, Malignant neoplasm progression, Gastric cancer, Headache, Migraine, Myalgia, Abdominal pain, Flatulence, Faeces discoloured, Nausea, Alopecia, Decreased appetite, Weight decreased, Breast discolouration, Insomnia, Pain in extremity, Off label use, Arthralgia, Diarrhoea, Abdominal pain upper, Off label use, Sinusitis, Eye infection, Anaemia, Pancreatic disorder, Vomiting, Nausea, Faeces discoloured, Abdominal pain upper, Polyp, Urinary tract infection, Fatigue, Diarrhoea, Abdominal distension, Stomach mass, Abdominal pain, Nausea, Vomiting, Diarrhoea, Fatigue, Polyp, Diarrhoea, Haemorrhoidal haemorrhage, Pain, Loss of personal independence in daily activities, Conjunctival laceration, Fall, Joint injury, Skin abrasion, Contusion, Pain, Fatigue, Pain, Nausea, Vomiting, Diarrhoea, Fall, Limb injury, Eye irritation, Walking aid user, Entropion, Asthenia, Fatigue, |
||||
LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANSOPRAZOLE, CLONAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CHOLESTYRAMINE, |
||||
| 107 | 26933208 |
CA |
25 | |
Haematochezia, Discomfort, Harvey-Bradshaw index increased, Anal fissure, Anal fistula, Cough, Muscle spasms, Nasopharyngitis, Urinary tract infection, Abdominal pain, Weight increased, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 108 | 26933431 |
GB |
49 | |
Perineal abscess, Psoriatic arthropathy, Condition aggravated, Arthralgia, Fatigue, Psoriasis, Drug specific antibody present, Urinary tract infection, Hidradenitis, Product dose omission issue, Product use issue, Intentional dose omission, Drug ineffective, Suspected off label use, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 109 | 26933559 |
US |
1 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 110 | 26933712 |
US |
1 | |
Urinary tract infection, |
||||
GEMCITABINE INTRAVESICAL, GEMCITABINE INTRAVESICAL, |
||||
| 111 | 26933725 |
US |
75 | 2 |
Fatigue, Asthenia, Chromaturia, Blood urine present, Productive cough, Cough, Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 112 | 26933819 |
GB |
36 | 1 |
Pneumonia, Dyspnoea, Fatigue, Lethargy, Urinary tract infection, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 113 | 26933839 |
US |
2 | |
Urinary tract infection, Klebsiella infection, Dysuria, |
||||
GEMCITABINE INTRAVESICAL, GEMCITABINE INTRAVESICAL, |
||||
| 114 | 26933876 |
CA |
1 | |
Decreased appetite, Urinary tract infection, Asthenia, |
||||
| 115 | 26933969 |
US |
71 | 2 |
Urinary tract infection, Confusional state, Device issue, Drug intolerance, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 116 | 26934045 |
US |
1 | |
Urinary tract infection, |
||||
BIMEKIZUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SPIRONOLACTONE, |
||||
| 117 | 26937240 |
55 | 2 | |
Cellulitis, Cellulitis, Sepsis, Goitre, Tracheal deviation, Therapy interrupted, Urinary tract infection, |
||||
DASATINIB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 118 | 26926669 |
EU |
72 | 2 |
Death, Pyuria, Urinary tract infection, |
||||
| 119 | 26926801 |
US |
2 | |
Cardiac failure, Hypotension, Urinary tract infection, Upper respiratory tract infection, |
||||
EFGARTIGIMOD ALFA, |
||||
| 120 | 26926931 |
US |
65 | 1 |
Nephrolithiasis, Urinary tract infection, |
||||
PEGCETACOPLAN, |
||||
| 121 | 26926934 |
US |
||
Opportunistic infection, Respiratory tract infection, Haematological infection, Skin infection, Urinary tract infection, Infection, |
||||
TALQUETAMAB, HUMAN IMMUNOGLOBULIN G, |
||||
| 122 | 26927225 |
US |
78 | 2 |
Metabolic dysfunction-associated liver disease, Drug ineffective, Constipation, Hepatic fibrosis, Food craving, Urinary tract infection, Scatolia, Hepatic steatosis, Gastroenteritis, Gastrooesophageal reflux disease, Abnormal faeces, Chronic kidney disease, Hypertension, Metabolic dysfunction-associated steatohepatitis, |
||||
HYDROCHLOROTHIAZIDE, LOSARTAN, OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE, DUPILUMAB, |
||||
| 123 | 26927324 |
US |
1 | |
Catheterisation cardiac, Cardio-respiratory arrest, Acute myocardial infarction, Urinary tract infection, Amnesia, Neck injury, Back injury, Sciatic nerve injury, |
||||
EVOLOCUMAB, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MAGNESIUM, |
||||
| 124 | 26927357 |
US |
2 | |
Urinary tract infection, |
||||
ORFORGLIPRON, |
||||
| 125 | 26927393 |
US |
2 | |
Cardiac failure congestive, Diabetes mellitus, Urinary tract infection, |
||||
TACROLIMUS, TACROLIMUS, EMPAGLIFLOZIN, |
||||
| 126 | 26927664 |
US |
71 | 1 |
Pneumonia, Urinary tract infection, Sepsis, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 127 | 26927752 |
US |
75 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 128 | 26927773 |
US |
75 | 2 |
Pelvic fracture, Fall, Head injury, Back injury, Shoulder fracture, Cellulitis, Colitis, Urinary tract infection, Dizziness, |
||||
DUPILUMAB, |
||||
| 129 | 26927829 |
US |
87 | |
Urinary tract infection, |
||||
BOSENTAN, |
||||
| 130 | 26928138 |
CA |
1 | |
Urinary tract infection, |
||||
ALBUTEROL SULFATE, |
||||
| 131 | 26928301 |
US |
2 | |
Large intestinal obstruction, Urinary tract infection, Arthralgia, |
||||
RISANKIZUMAB-RZAA, |
||||
| 132 | 26928366 |
US |
78 | 1 |
Urinary tract infection, |
||||
RELUGOLIX, RELUGOLIX, ATORVASTATIN CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, AZELASTINE, |
||||
| 133 | 26928598 |
CA |
35 | 2 |
Skin discolouration, Incorrect dose administered, Cyanosis, Liver disorder, Presyncope, Fall, Pain, Hidradenitis, Condition aggravated, Hyperhidrosis, Cold sweat, Urinary tract infection, COVID-19, Pathogen resistance, Dyspepsia, Insomnia, Diarrhoea, Nausea, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 134 | 26928942 |
GB |
80 | 2 |
Urinary tract infection, |
||||
DAPAGLIFLOZIN, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 135 | 26929041 |
EU |
84 | 2 |
Pulmonary oedema, Cardiac failure, Urinary tract infection, Renal failure, |
||||
QUETIAPINE, FUROSEMIDE, MEROPENEM, |
||||
| 136 | 26929154 |
US |
47 | 2 |
White blood cell count increased, Headache, Urinary tract infection, |
||||
CLADRIBINE, CLADRIBINE, CLADRIBINE, |
||||
| 137 | 26929811 |
1 | ||
Urinary tract infection, Platelet count decreased, Haemorrhage, Haemoglobin decreased, |
||||
ELTROMBOPAG, ELTROMBOPAG OLAMINE, |
||||
| 138 | 26929975 |
US |
41 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 139 | 26930123 |
EU |
82 | 2 |
Eructation, Pulmonary hypertension, Hiatus hernia, Inflammatory marker increased, Hepatic cyst, Gait disturbance, Coronary artery disease, Decreased appetite, Urinary tract infection, Acute kidney injury, Aplastic anaemia, Urinary retention, Wound dehiscence, Arterial haemorrhage, Diverticulum intestinal, Pancreatic steatosis, Myocardial infarction, Haemarthrosis, Tricuspid valve incompetence, Myelodysplastic syndrome, Impaired healing, General physical health deterioration, Cardiogenic shock, Faecaloma, Left ventricular dysfunction, Abdominal discomfort, Arthralgia, Femoral hernia incarcerated, Fall, Mitral valve incompetence, Dyspnoea, Wound infection pseudomonas, Postoperative wound infection, Escherichia infection, Joint dislocation, Aortic valve stenosis, Cardiovascular disorder, Anaemia, Gastrointestinal haemorrhage, Lymphatic fistula, Seroma, Groin pain, |
||||
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE, PANTOPRAZOLE, PANTOPRAZOLE, EDOXABAN TOSYLATE, EDOXABAN TOSYLATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, SIMVASTATIN, TORSEMIDE, TORSEMIDE, CLOPIDOGREL BISULFATE, AMIODARONE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, VALSARTAN, VALSARTAN ORAL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FENTANYL, ESOMEPRAZOLE, ESOMEPRAZOLE, TORSEMIDE, TORSEMIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, FOLIC ACID, LACTULOSE, TROSPIUM CHLORIDE, TROSPIUM CHLORIDE, |
||||
| 140 | 26930276 |
CA |
32 | 2 |
Pneumonia, Heart rate increased, Tachycardia, Sinusitis, Anxiety, Fungal infection, Product administration error, Bacterial infection, Eosinophil count abnormal, Musculoskeletal chest pain, Migraine, Rhinitis, Oropharyngeal pain, Asthma, Infection, Restrictive pulmonary disease, Terminal insomnia, Middle insomnia, Dyspnoea exertional, Malaise, Psoriasis, Eczema, Abdominal pain, Dyspnoea, Obstructive airways disorder, Urinary tract infection, Sleep disorder, Therapeutic response decreased, Upper-airway cough syndrome, Nasopharyngitis, Loss of personal independence in daily activities, Influenza, Sleep disorder due to a general medical condition, Vertigo, Pain, Productive cough, Tooth abscess, Rales, Forced expiratory volume decreased, Drug ineffective, Dizziness, Nasal congestion, Therapeutic product effect decreased, Full blood count abnormal, Cough, Vomiting, Diarrhoea, Blood pressure increased, Nasal discharge discolouration, Wheezing, Ear infection, Decreased activity, Emphysema, Stress, Feeding disorder, Urticaria, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MONTELUKAST SODIUM, MONTELUKAST, TERBUTALINE SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, IPRATROPIUM BROMIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, CICLESONIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, QUETIAPINE FUMARATE, QUETIAPINE, MONTELUKAST SODIUM, AMLODIPINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, EPINEPHRINE, EPINEPHRINE, |
||||
| 141 | 26930434 |
US |
57 | 2 |
Femur fracture, Fall, Fall, Urinary tract infection, Spinal pain, Pain in jaw, Feeling abnormal, Abdominal pain upper, Diarrhoea, |
||||
ABALOPARATIDE, |
||||
| 142 | 26930506 |
BR |
40 | 2 |
Decreased immune responsiveness, Lymphocyte count decreased, Urinary tract infection, Alopecia, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 143 | 26930797 |
68 | 2 | |
Fall, Pneumonia, Urinary tract infection, Haematological infection, Therapy interrupted, Malaise, |
||||
DEUTETRABENAZINE, |
||||
| 144 | 26930990 |
US |
||
Iron overload, Urinary tract infection, Weight abnormal, Menopausal symptoms, Off label use, |
||||
RUXOLITINIB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, BENZONATATE, CALCIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, EPINEPHRINE, |
||||
| 145 | 26921458 |
GB |
66 | 2 |
Secondary progressive multiple sclerosis, Condition aggravated, Headache, Dry skin, Cough, Skin exfoliation, Pruritus, Dizziness, Urinary tract infection, Urinary tract infection, |
||||
SIPONIMOD, SIPONIMOD, |
||||
| 146 | 26921584 |
AU |
90 | 1 |
Blood potassium increased, Diarrhoea, Urinary tract infection, Malaise, |
||||
DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, |
||||
| 147 | 26921654 |
US |
74 | 1 |
Fall, Urinary tract infection, |
||||
TREPROSTINIL, TREPROSTINIL, EMPAGLIFLOZIN, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, TIOTROPIUM BROMIDE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, FLUTICASONE PROPIONATE AND SALMETEROL, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ALBUTEROL SULFATE, LOSARTAN POTASSIUM, LOSARTAN, HEPARIN SODIUM, LISINOPRIL, AMLODIPINE BESYLATE, POLYETHYLENE GLYCOL, DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG, DOCUSATE SODIUM AND SENNOSIDES, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PRAVASTATIN SODIUM, FUROSEMIDE, |
||||
| 148 | 26921754 |
CA |
25 | |
Haematochezia, Anorectal discomfort, Faeces discoloured, Defaecation urgency, Weight decreased, Influenza like illness, Arthralgia, Dyspepsia, Urinary tract infection, Intentional dose omission, Suspected off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 149 | 26921837 |
EU |
59 | 2 |
Thrombotic microangiopathy, Deep vein thrombosis, Neuropathy peripheral, Clostridium difficile infection, Urinary tract infection, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, BORTEZOMIB, LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 150 | 26921856 |
JP |
65 | |
Ureteric obstruction, Urinary tract infection, Lymphadenopathy, Malignant neoplasm progression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 151 | 26922129 |
US |
||
Inappropriate schedule of product administration, Urinary tract infection, |
||||
MITOMYCIN, MITOMYCIN, |
||||
| 152 | 26922488 |
US |
77 | 2 |
Urinary tract infection, Pneumonia, Hypotension, |
||||
PANCRELIPASE, |
||||
| 153 | 26922824 |
US |
39 | 2 |
Joint swelling, Frequent bowel movements, Abdominal pain lower, Blood creatinine increased, Urinary tract infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VOCLOSPORIN, FUROSEMIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, DARBEPOETIN ALFA, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLIC ACID, SPIRONOLACTONE, LISINOPRIL, HYDROXYCHLOROQUINE SULFATE, EMPAGLIFLOZIN, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 154 | 26922868 |
US |
2 | |
Urinary tract infection, |
||||
PIMAVANSERIN TARTRATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PANTOPRAZOLE SODIUM, CLONAZEPAM, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, GABAPENTIN, TROSPIUM CHLORIDE, VITAMIN C, ESCITALOPRAM OXALATE, ESCITALOPRAM, RANOLAZINE, FERROUS SULFATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MAGNESIUM, METHENAMINE HIPPURATE, MELATONIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 155 | 26922983 |
US |
57 | |
Urinary tract infection, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 156 | 26922990 |
GB |
||
Urinary tract infection, |
||||
DAPAGLIFLOZIN, |
||||
| 157 | 26923181 |
BR |
2 | |
Drug intolerance, Immunodeficiency, Epistaxis, Loss of consciousness, Haemangioma rupture, Liver injury, Spinal cord disorder, Spinal cord injury, Metastases to spine, Metastases to bone, Metastasis, Metastases to bone, Metastases to liver, Immunodeficiency, Face injury, Skin exfoliation, Dry throat, Alopecia, Erythema, Dry skin, Vulvovaginal dryness, Vulvovaginal discomfort, Vulvovaginal burning sensation, Nasal dryness, Skin disorder, Pruritus, Neoplasm, Gait disturbance, Tumour marker increased, Reflux gastritis, Discouragement, Visual impairment, Greater trochanteric pain syndrome, Feeding disorder, Haemangioma, Disease progression, Weight decreased, Illness, Aphthous ulcer, Oral herpes, Swelling of eyelid, Sinusitis, Rhinitis, Rhinitis allergic, Eyelid sensory disorder, Vein disorder, Frostbite, Ocular hyperaemia, Haemorrhoids, Hair texture abnormal, Trichorrhexis, Eyelid ptosis, Rectocele, Gastrointestinal disorder, Hiatus hernia, Nasal pruritus, Dry eye, Head discomfort, PIK3CA-activated mutation, Swelling, Abdominal discomfort, Head injury, Nasal injury, Skin lesion, Wound, Injury, Oestrogen deficiency, Drug ineffective, Panic disorder, Nasal discomfort, Haematoma, Asthenopia, Hypermetropia, Astigmatism, Petechiae, Dyspnoea, Skeletal injury, Phlebitis, Oral pain, Nasal disorder, Eye swelling, Anosmia, Movement disorder, Pain, Vulvovaginal exfoliation, Chills, Paraesthesia, White blood cell count decreased, Neutrophil count decreased, Pyrexia, Fatigue, Constipation, Dry mouth, Application site bruise, Application site pain, Ear disorder, Urinary tract infection, Skin atrophy, Lip dry, Pain, Pain in extremity, Bone pain, Dysstasia, Application site swelling, Arthralgia, Insomnia, Malaise, Product availability issue, |
||||
FULVESTRANT, ANASTROZOLE, ANASTROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ERGOCALCIFEROL, ACONITUM NAPELLUS, BRYONIA ALBA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS, KALI BICHROMICUM, KALI LODATUM, ZINCUM GLUCONICUM., DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, ACONITUM NAPELLUS, ALLIUM CEPA, GELSEMIUM SEMP., ZINCUM GLUCONICUM, BAPTISIA TINCTORIA, ECHINACEA ANGUSTIFOLIA, EUPATORIUM PERFOLIATUM, LOMATIUM DISSECTUM, PUERARIA LOBATA, TRIFOLIUM PRATENSE, PHYTOLACCA DECANDRA, ALLIUM CEPA, ARSENICUM IODATUM, BARYTA CARBONICA, BROMIUM, CALCAREA CARBONICA, KALI MURIATICUM, LACHESIS MUTUS, MERCURIUS SOLUBILIS, SILICEA, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL, |
||||
| 158 | 26923255 |
US |
83 | 2 |
Pyrexia, Decreased appetite, Urinary tract infection, |
||||
VIBEGRON, |
||||
| 159 | 26923350 |
SG |
77 | 2 |
Urinary tract infection, Bacterial infection, Cytomegalovirus viraemia, |
||||
RITUXIMAB, METHYLPREDNISOLONE, TOFACITINIB, TOFACITINIB CITRATE, |
||||
| 160 | 26923468 |
GB |
71 | 2 |
Urinary tract infection, Product storage error, Rheumatoid arthritis, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 161 | 26923856 |
RU |
2 | |
Infusion related reaction, Neutropenia, Herpes simplex, Bacteriuria, Leukocyturia, Respiratory tract infection viral, Thrombocytopenia, Urinary tract infection, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, OBINUTUZUMAB, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, BENDAMUSTINE HCL, |
||||
| 162 | 26924094 |
US |
81 | 2 |
Urinary tract infection, |
||||
BRENSOCATIB, |
||||
| 163 | 26924170 |
US |
2 | |
Flushing, Throat tightness, Urinary tract infection, Vasodilatation, Insomnia, Fatigue, Headache, Feeling abnormal, Off label use, Wrong technique in product usage process, |
||||
BRENSOCATIB, |
||||
| 164 | 26924258 |
US |
72 | 2 |
Myalgia, Arthralgia, Dyspnoea, Fatigue, Pyrexia, Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 165 | 26924464 |
EU |
2 | |
Osteoarthritis, Deep vein thrombosis, Mitral valve incompetence, Sciatica, Spinal osteoarthritis, Urinary tract infection, Vascular calcification, Metabolic syndrome, Dyslipidaemia, Oral fungal infection, Paranasal sinus inflammation, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, SECUKINUMAB, USTEKINUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 166 | 26924527 |
US |
||
Hypoxia, Pneumonia, Hyperglycaemia, Peripheral sensory neuropathy, Dyspnoea, Lymphocyte count decreased, Urinary tract infection, Gastrointestinal disorder, Fatigue, Diarrhoea, Platelet count decreased, Muscular weakness, Cough, Upper respiratory tract infection, Infestation, Anaemia, White blood cell count decreased, Neutrophil count decreased, Nausea, Constipation, Infection, Cognitive disorder, Oedema peripheral, Rash maculo-papular, Peripheral motor neuropathy, Vomiting, Insomnia, Gastrooesophageal reflux disease, Blood creatinine increased, Intentional product use issue, |
||||
DARATUMUMAB, IXAZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 167 | 26924571 |
CN |
64 | 2 |
Urinary tract infection, Pollakiuria, Dysuria, Micturition urgency, Immune-mediated cystitis, |
||||
RIBOCICLIB, |
||||
| 168 | 26924586 |
EU |
1 | 2 |
Urinary tract infection, Urinary tract infection, |
||||
ONASEMNOGENE ABEPARVOVEC-XIOI, |
||||
| 169 | 26924639 |
US |
76 | 2 |
Urinary tract infection, Diarrhoea, Malaise, |
||||
AVAPRITINIB, AMOXICILLIN AND CLAVULANATE POTASSIUM, BACLOFEN, DIPHENHYDRAMINE HYDROCHLORIDE, PYRITHIONE ZINC, CLONIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXAZOSIN, DOXAZOSIN MESYLATE, EPINEPHRINE, ADRENALINUM, FAMOTIDINE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, TIRZEPATIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, TRICITRATES, POTASSIUM CITRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 170 | 26924677 |
EU |
59 | 2 |
Deep vein thrombosis, Neuropathy peripheral, Thrombotic microangiopathy, Clostridium difficile infection, Urinary tract infection, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, LENALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 171 | 26924958 |
US |
86 | 2 |
Sepsis, Renal disorder, Urinary tract infection, Blood pressure increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 172 | 26925117 |
AU |
2 | |
Multiple sclerosis, Kidney infection, Urinary tract infection, Migraine, Candida infection, Inappropriate schedule of product administration, Sinusitis, Joint dislocation, Ear infection, |
||||
OFATUMUMAB, OFATUMUMAB, OFATUMUMAB, |
||||
| 173 | 26925420 |
US |
87 | 1 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 174 | 26925436 |
US |
1 | |
Herpes zoster, Urinary tract infection, |
||||
DUPILUMAB, PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH, |
||||
| 175 | 26925612 |
US |
||
Generalised tonic-clonic seizure, Nephrolithiasis, Vomiting projectile, Dehydration, Hypertension, Urinary tract infection, Illness, Weight decreased, Feeling abnormal, Blood glucose increased, Therapy cessation, |
||||
HYDROXYCHLOROQUINE SULFATE, |
||||
| 176 | 26925777 |
US |
2 | |
Urinary tract infection, Off label use, |
||||
VALBENAZINE, |
||||
| 177 | 26925832 |
US |
1 | |
Urinary tract infection, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CLOPIDOGREL, MIRTAZAPINE, DONEPEZIL HYDROCHLORIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE, LUBIPROSTONE, POLYETHYLENE GLYCOL 3350, |
||||
| 178 | 26925954 |
CA |
2 | |
Systemic lupus erythematosus, Arthritis, Arthralgia, Joint stiffness, Myofascial pain syndrome, Joint swelling, Muscular weakness, Butterfly rash, Swelling face, Drug ineffective, Fatigue, Tenderness, Skin tightness, Ophthalmic migraine, Urinary tract infection, Cervix neoplasm, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 179 | 26925992 |
66 | 2 | |
Urinary tract infection, |
||||
| 180 | 26926014 |
IN |
66 | 1 |
Urinary tract infection, |
||||
CRIZOTINIB, |
||||
| 181 | 26926057 |
US |
69 | 1 |
Macular degeneration, Urinary tract infection, Sinus disorder, Asthenia, Vision blurred, Malaise, |
||||
DUPILUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LORATADINE, LORATADINE TABLET, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LURASIDONE HYDROCHLORIDE, LISINOPRIL, |
||||
| 182 | 26928720 |
20 | 1 | |
Urinary tract infection, Cystitis viral, Glucose urine present, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ETOPOSIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE, PHENAZOPYRIDINE, |
||||
| 183 | 26928880 |
74 | 2 | |
Urinary tract infection, Sepsis, |
||||
SECUKINUMAB, |
||||
| 184 | 26929029 |
71 | 2 | |
Pneumonia, Urinary tract infection, Fatigue, Cough, Asthenia, |
||||
LENALIDOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, ALPRAZOLAM, ALPRAZOLAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 185 | 26929171 |
2 | ||
Urinary tract infection, Infection, |
||||
TAFAMIDIS, |
||||
| 186 | 26914914 |
US |
83 | 2 |
Hallucination, Urinary tract infection, |
||||
CAPIVASERTIB, BENZONATATE, CEPHALEXIN, ERGOCALCIFEROL, FULVESTRANT, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DENOSUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 187 | 26914992 |
IN |
2 | |
Diabetes mellitus, Neutropenia, Musculoskeletal disorder, Asthenia, Vitamin D decreased, Vitamin B12 decreased, Glycosylated haemoglobin increased, Urinary tract infection, Off label use, Product dose omission issue, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 188 | 26915119 |
BR |
2 | |
Epistaxis, Neoplasm malignant, Metastases to bone, Breast cancer, Loss of consciousness, Haemangioma, Spinal cord neoplasm, Skull fracture, Spinal cord injury, Metastasis, Metastases to central nervous system, Immunodeficiency, Brain neoplasm, Metastases to liver, Nasal dryness, Skin exfoliation, Skin fissures, Dry skin, Skin atrophy, Tumour marker abnormal, Tumour marker increased, Pain, Discomfort, Hiatus hernia, Reflux gastritis, Discouragement, Visual impairment, Movement disorder, Greater trochanteric pain syndrome, Feeding disorder, Hernia, Burning sensation, Pain of skin, Abdominal discomfort, Malaise, Hepatic lesion, White blood cell count decreased, Neutrophil count decreased, Rhinitis allergic, Sinusitis, Bowel movement irregularity, PIK3CA-activated mutation, Vein disorder, Ill-defined disorder, Pruritus, Lip dry, Erythema, Hair texture abnormal, Swelling, Atrophic vulvovaginitis, Vulvovaginal burning sensation, Vulvovaginal discomfort, Vulvovaginal dryness, Urinary tract infection, Inadequate lubrication, Device physical property issue, Clavicle fracture, Panic disorder, Oestrogen deficiency, Injury, Pain, Alopecia, Skin laceration, Haematoma, Macule, Central nervous system lesion, Vaginal disorder, Haemorrhoids, Spinal disorder, Angiopathy, Neoplasm, Haemangioma of bone, Carpal tunnel syndrome, Head discomfort, Weight decreased, Insomnia, Drug intolerance, Drug ineffective, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, EXEMESTANE, EXEMESTANE, CLONAZEPAM, FULVESTRANT, |
||||
| 189 | 26915242 |
US |
82 | |
Therapy interrupted, Urinary tract infection, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 190 | 26915676 |
57 | ||
Urinary tract infection, Device deployment issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 191 | 26915719 |
BR |
2 | |
Vulvovaginal injury, Spinal fracture, Vein rupture, Metastases to bone, Metastases to spine, Metastases to liver, Metastasis, Haemorrhage, Hydronephrosis, Urinary retention, Seizure, Breast cancer, Malignant neoplasm progression, Nail cuticle fissure, Epistaxis, Dry skin, Dry mouth, Constipation, Vulvovaginal dryness, Drug ineffective, Petechiae, Skin tightness, Visual impairment, Skin fissures, Skin atrophy, Dry throat, Nasal mucosal disorder, Rhinalgia, Secretion discharge, Insomnia, Throat irritation, Hair texture abnormal, Skin exfoliation, Breast disorder, Tumour marker increased, Calcification metastatic, Weight increased, Flatulence, Reflux gastritis, Hiatus hernia, Gastritis, Muscle spasms, Vitamin B12 deficiency, Feeding disorder, Balance disorder, Head injury, Fall, Dermal absorption impaired, Thermal burn, Nasal congestion, Eye swelling, Phlebitis, Rhinitis allergic, Allergic sinusitis, Decreased immune responsiveness, Gastric polyps, Skeletal injury, Pelvic bone injury, Epistaxis, Oropharyngeal discomfort, Hypersensitivity, Discomfort, Quality of life decreased, Rectocele, Bone lesion, Product distribution issue, Thinking abnormal, Feeling abnormal, Carbohydrate antigen 15-3 increased, PIK3CA-activated mutation, Quality of life decreased, Feeding disorder, Sensory disturbance, Skin discolouration, COVID-19, Bone pain, Condition aggravated, Anosmia, Malaise, Gene mutation, Urinary tract infection, Oral pain, Muscle injury, Hepatic mass, Dysbiosis, Oral disorder, Speech disorder, Chills, Lip swelling, Gait disturbance, Gastrointestinal disorder, Pain, Depressed mood, Myalgia, Atrophic vulvovaginitis, Nasal disorder, Head injury, Malaise, Tumour marker abnormal, Central nervous system lesion, Hepatic lesion, Cervix disorder, Uterine leiomyoma, Bacteriuria, Swelling face, Pruritus, Erythema, White blood cell count decreased, Nausea, Peripheral swelling, Vomiting, Diarrhoea, Nasopharyngitis, Dizziness, Abdominal pain upper, Cough, Retching, Fatigue, Sinusitis, Infection, Rhinitis, Abdominal pain, Dyspnoea, Abdominal discomfort, Drug resistance, Pain, Pain in extremity, Head discomfort, Decreased appetite, Vision blurred, Illness, Weight decreased, Arthralgia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PANTOPRAZOLE, FULVESTRANT, FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ALPELISIB, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, LORATADINE, LORATADINE ORAL, EXEMESTANE, CLONAZEPAM, CAPECITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, ERGOCALCIFEROL, |
||||
| 192 | 26915799 |
GB |
1 | |
Haematological infection, Urinary tract infection, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 193 | 26916188 |
EU |
67 | 1 |
Urinary tract infection, Diabetes mellitus inadequate control, Drug ineffective, Dysuria, Urine odour abnormal, Malaise, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, PIOGLITAZONE, ATENOLOL, |
||||
| 194 | 26916360 |
EU |
||
Immunodeficiency, Superinfection bacterial, Lymphoedema, Pancytopenia, Neoplasm progression, Skin lesion, Virologic failure, Laboratory test abnormal, Multiple-drug resistance, Dysuria, Toxicity to various agents, Dyslipidaemia, Glucose tolerance impaired, Drug ineffective, Urinary tract infection, Hypertension, Pyrexia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ABACAVIR SULFATE, ABACAVIR, AZITHROMYCIN DIHYDRATE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, MARAVIROC, EFAVIRENZ, EMTRICITABINE, LAMIVUDINE, ETRAVIRINE, RALTEGRAVIR, LOPINAVIR AND RITONAVIR, LOPINAVIR AND RITONAVIR, FLUCONAZOLE, RITONAVIR, DARUNAVIR, ZIDOVUDINE, EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE, DOLUTEGRAVIR SODIUM, NELFINAVIR MESYLATE, TENOFOVIR DISOPROXIL FUMARATE, ABACAVIR SULFATE, |
||||
| 195 | 26916703 |
US |
31 | 2 |
Dyspnoea, Urinary tract infection, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 196 | 26916764 |
US |
6 | 2 |
Urinary tract infection, Fungal infection, |
||||
EMPAGLIFLOZIN, |
||||
| 197 | 26916872 |
EU |
2 | |
Febrile infection, Oedema peripheral, Urinary tract infection, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, |
||||
| 198 | 26917161 |
US |
82 | |
Inappropriate schedule of product administration, Blood pressure abnormal, Cardiac disorder, Urinary tract infection, |
||||
MITOMYCIN, MITOMYCIN, MITOMYCIN, |
||||
| 199 | 26917507 |
US |
77 | 2 |
Dysphagia, Vomiting, Blood pressure increased, Urinary tract infection, Sensation of foreign body, Blood glucose increased, Dizziness, Stomatitis, Weight decreased, Decreased appetite, Constipation, Anxiety, Insomnia, Dyspnoea, Off label use, |
||||
CABOZANTINIB, NIVOLUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, TIZANIDINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ESZOPICLONE, GABAPENTIN, HUMAN INSULIN, CARVEDILOL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACARBOSE, ROSUVASTATIN CALCIUM, |
||||
| 200 | 26917779 |
US |
20 | 2 |
Urinary tract infection, Enuresis, |
||||
ILOPERIDONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30